Brandon Couillard
Stock Analyst at Wells Fargo
(4.30)
# 375
Out of 4,876 analysts
126
Total ratings
56.47%
Success rate
14.39%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $260 → $245 | $243.47 | +0.63% | 10 | Jun 9, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $260 → $245 | $242.60 | +0.99% | 10 | Jun 9, 2025 | |
| MLAB Mesa Laboratories | Maintains: Underweight | $120 → $100 | $96.36 | +3.78% | 2 | May 30, 2025 | |
| TECH Bio-Techne | Initiates: Overweight | $59 | $52.80 | +11.74% | 1 | May 30, 2025 | |
| MYGN Myriad Genetics | Downgrades: Equal-Weight | $22 → $6 | $5.33 | +12.57% | 2 | May 8, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,125 → $1,200 | $1,193.31 | +0.56% | 5 | May 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $105 → $78 | $89.59 | -12.94% | 3 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $580 → $570 | $412.12 | +38.31% | 5 | Apr 24, 2025 | |
| A Agilent Technologies | Maintains: Hold | $135 → $116 | $119.42 | -2.86% | 22 | Apr 21, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $130 → $102 | $98.79 | +3.25% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $60 | $42.18 | +42.25% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $22 | $13.74 | +60.12% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $415 → $420 | $354.91 | +18.34% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $201.46 | +19.13% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $187.74 | +38.49% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $73.19 | +9.30% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $28 → $24 | $19.29 | +24.42% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $51.81 | +64.06% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $124.21 | +44.92% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.38 | +320.17% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $19.65 | +17.05% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.81 | +1,510.90% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.03 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.52 | +336.51% | 2 | Oct 13, 2017 |
Bio-Rad Laboratories
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $260 → $245
Current: $243.47
Upside: +0.63%
Bio-Rad Laboratories
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $260 → $245
Current: $242.60
Upside: +0.99%
Mesa Laboratories
May 30, 2025
Maintains: Underweight
Price Target: $120 → $100
Current: $96.36
Upside: +3.78%
Bio-Techne
May 30, 2025
Initiates: Overweight
Price Target: $59
Current: $52.80
Upside: +11.74%
Myriad Genetics
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $5.33
Upside: +12.57%
Mettler-Toledo International
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,193.31
Upside: +0.56%
GeneDx Holdings
May 1, 2025
Maintains: Equal-Weight
Price Target: $105 → $78
Current: $89.59
Upside: -12.94%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Overweight
Price Target: $580 → $570
Current: $412.12
Upside: +38.31%
Agilent Technologies
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $119.42
Upside: -2.86%
Revvity
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $98.79
Upside: +3.25%
Apr 17, 2025
Maintains: Overweight
Price Target: $75 → $60
Current: $42.18
Upside: +42.25%
Apr 17, 2025
Maintains: Overweight
Price Target: $25 → $22
Current: $13.74
Upside: +60.12%
Feb 13, 2025
Maintains: Overweight
Price Target: $415 → $420
Current: $354.91
Upside: +18.34%
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $201.46
Upside: +19.13%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $187.74
Upside: +38.49%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $73.19
Upside: +9.30%
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $19.29
Upside: +24.42%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $51.81
Upside: +64.06%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $124.21
Upside: +44.92%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.38
Upside: +320.17%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $19.65
Upside: +17.05%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.81
Upside: +1,510.90%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.03
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.52
Upside: +336.51%